Tag: Ellipsys

“EndoAVF 2.0” projects evaluated in CX debate

The advent of endovascular arteriovenous fistula (endoAVF) creation with the development of the Ellipsys (Medtronic) and WavelinQ (BD) systems marks a “major innovation in...
endoAVF

Vascular access creation: EndoAVF keeps future options open, but is not...

Based on over four years of experience in a single centre, Robert Shahverdyan (Asklepios Klinik Barmbek, Hamburg, Germany) claims that endovascular arteriovenous fistula (endoAVF)...
haemodialysis patients cannulation

Study indicates lower wound infection and surgical reintervention rates in pAVF...

A single-centre, retrospective, comparative study, which was presented at the July 2021 Journal of Vascular Surgery (JVS) Journal Club (14 July, online), has found...

Ellipsys™ Vascular Access System provides consistently great outcomes for AV fistula...

 Alexandros Mallios (Paris, France) and Robert Shahverdyan (Hamburg, Germany) talk to Vascular News about some of the benefits of the Ellipsys™ Vascular Access System...
ellipsys five-year data

Benefits of percutaneous fistula creation further bolstered by five-year Ellipsys data

The Ellipsys vascular access system (Avenu Medical/Medtronic) can be used to easily and safely create durable percutaneous arteriovenous fistulas (pAVFs) for haemodialysis—with new, long-term...

Cannulation difficulties among biggest hurdles for device-created fistulas

Difficulties in cannulation are currently as pressing as any other challenge facing patients who undergo device-enabled arteriovenous fistula (AVF) creation for dialysis. This was...

LINC 2021: Positive first-time data presented for IN.PACT AV DCB and...

New data presented for the first time at LINC 2021 (The Leipzig Interventional Course; 25–29 January, online) support the use of drug-coated balloons (DCBs)...